Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

被引：131

作者：

Carter, Melody C. ^{[1
]}

Robyn, Jamie A.

Bressler, Peter B.

Walker, John C.

Shapiro, Gail G.

Metcalfe, Dean D.

机构：

[1] NIAID, NIH, Lab Allerg Dis, Bethesda, MD 20892 USA

[2] Carolina Allergy & Asthma, Chapel Hill, NC USA

[3] Univ Washington, Childrens Hosp, NW Allery & Asthma Ctr, Richland, WA USA

[4] Reg Med Ctr, Richland, WA USA

[5] Univ Washington, Sch Med, NW Allergy & Asthma Ctr, Seattle, WA 98195 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 119卷 / 06期

关键词：

D O I：

10.1016/j.jaci.2007.03.032

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1550 / 1551

页数：2

共 4 条

[1] Omalizumab-induced reductions in mast cell FcεRI expression and function [J].

Beck, LA ;

Marcotte, GV ;

MacGlashan, D ;

Togias, A ;

Saini, S .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530

[2]

MacGlashan DW, 1997, INT ARCH ALLERGY IMM, V113, P45

[3] Treatment of allergic asthma with monoclonal anti-IgE antibody [J].

Milgrom, H ;

Fick, RB ;

Su, JQ ;

Reimann, JD ;

Bush, RK ;

Watrous, ML ;

Metzger, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1966-1973

[4] Systemic mastocytosis [J].

Robyn, J ;

Metcalfe, DD .

ADVANCES IN IMMUNOLOGY, VOL 89, 2006, 89 :169-243

← 1 →